Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosisBarbara Delage, Peter W. Szlosarek(St Bartholomew's Hospital)Cell Death and DiseaseJuly 5, 201210.1038/cddis.2012.83Cited by 151SaveCiteExport RISWatch citationsRelated PapersExpansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms|JTO Clinical and Research Reports|2020|30A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma|Pharmacological Reports|2023|5